S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)

CalciMedica (CALC) Earnings Date, Estimates & Call Transcripts

$4.01
-0.33 (-7.60%)
(As of 09:30 AM ET)
Skip Charts & View Estimated and Actual Earnings Data

CALC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CALC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

CalciMedica Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.47)($0.47)($0.47)
Q2 20241($0.54)($0.54)($0.54)
Q3 20241($0.61)($0.61)($0.61)
Q4 20241($0.61)($0.61)($0.61)
FY 20244($2.23)($2.23)($2.23)

CALC Earnings Date and Information

CalciMedica has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 10th, 2024 based off prior year's report dates.

CalciMedica Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/10/2024
Estimated)
------- 
11/9/2023Q3 2023($1.14)($0.82)+$0.32($0.82)--
8/10/2023Q2 2023($1.02)($1.11)($0.09)($1.11)--
5/12/2023Q1 2023-($23.43)($23.43)($23.43)--
11/10/2022Q3 2022($5.32)($6.44)($1.12)($6.44)--
8/11/2022Q2 2022($5.32)($5.32)-($5.32)--
5/10/2022Q1 2022($4.76)($6.72)($1.96)($6.72)--
3/10/2022Q4 2021($5.04)($5.74)($0.70)($5.74)--
11/11/2021Q3 2021($4.90)($5.32)($0.42)($5.32)--
8/11/2021Q2 2021($6.58)($5.04)+$1.54($5.04)--
5/12/2021Q1 2021($6.30)($7.56)($1.26)($7.56)--

CalciMedica Earnings - Frequently Asked Questions

When is CalciMedica's earnings date?

CalciMedica has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 10th, 2024 based off last year's report dates. Learn more on CALC's earnings history.

How much profit does CalciMedica generate each year?

CalciMedica (NASDAQ:CALC) has a recorded net income of -$34.36 million. CALC has generated -$25.59 earnings per share over the last four quarters.

What is CalciMedica's EPS forecast for next year?

CalciMedica's earnings are expected to grow from ($2.04) per share to ($1.99) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:CALC) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners